Processa Pharmaceuticals (PCSA) Sees Notable Stock Increase After Regulatory Nod
Following the recent regulatory approval, Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) is witnessing a remarkable increase in its stock value. As per the latest market update, the shares of PCSA have surged by 22.06%, reaching $2.08. FDA Grants Approval for Next Generation Capecitabine Today, Processa Pharmaceuticals announced that its primary product candidate, Next Generation Capecitabine (NGC-Cap), […]